{
    "clinical_study": {
        "@rank": "18495", 
        "arm_group": {
            "arm_group_label": "PLGA Poly-L-Lysine Scaffold", 
            "arm_group_type": "Experimental"
        }, 
        "brief_summary": {
            "textblock": "-  To evaluate whether the Scaffold is safe and feasible for the treatment of complete\n           functional spinal cord injury as determined by no degradation in paralysis level or\n           sensory motor neurological function beyond that typically seen in the ASIA A subject.\n\n        -  To gather preliminary evidence of clinical effectiveness of the Scaffold, including\n           improvement of ASIA Impairment Scale, sensory scores, motor scores, bladder and bowel\n           function, neurological tests, and The Spinal Cord Independence Measure III."
        }, 
        "brief_title": "Pilot Study of Clinical Safety of the PLGA Poly-L-Lysine Scaffold for the Treatment of Complete (ASIA A) Traumatic Acute Spinal Cord Injury", 
        "condition": "Traumatic Acute Spinal Cord Injury", 
        "condition_browse": {
            "mesh_term": [
                "Spinal Cord Injuries", 
                "Wounds and Injuries"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Aged 18 - 55 years\n\n          -  ASIA A traumatic spinal cord injury (T3-T11) confirmed by neurosurgeon, occurring\n             within past 10 days\n\n          -  Non-penetrating contusion injury no less than 4 mm diameter and limited to 2\n             contiguous vertebral levels\n\n        Exclusion Criteria:\n\n          -  Incomplete spinal cord injury (ASIA B, C, D, E)\n\n          -  Terminally ill\n\n          -  Significant spinal conditions other than lesion to be treated\n\n          -  Spinal cord injury associated with traumatic brain injury\n\n          -  Subject on long term mechanical ventilation\n\n          -  Penetrating injuries\n\n          -  Radiographic evidence of parenchymal disassociation or anatomic transection where the\n             contusion completely bridges a full cross-section of the spinal cord"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "55 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "5", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "May 1, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02138110", 
            "org_study_id": "InVivo-100-101"
        }, 
        "intervention": {
            "arm_group_label": "PLGA Poly-L-Lysine Scaffold", 
            "intervention_name": "PLGA Poly-L-Lysine Scaffold", 
            "intervention_type": "Device"
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "No", 
        "keyword": [
            "Spinal Cord Injury (SCI)", 
            "Complete (ASIA A) Traumatic Acute Spinal Cord Injury"
        ], 
        "lastchanged_date": "May 12, 2014", 
        "location": [
            {
                "contact": {
                    "email": "oscarf@email.arizona.edu", 
                    "last_name": "Oscar Furet, MD", 
                    "phone": "520-626-8000"
                }, 
                "facility": {
                    "address": {
                        "city": "Tucson", 
                        "country": "United States", 
                        "state": "Arizona", 
                        "zip": "85724"
                    }, 
                    "name": "University of Arizona"
                }, 
                "investigator": {
                    "last_name": "Ali A Baaj, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "peggy.boltes@cnsa.com", 
                    "last_name": "Peggy Boltes", 
                    "phone": "704-831-4006"
                }, 
                "contact_backup": {
                    "email": "Marybeth.Whitney@carolinashealthcare.org", 
                    "last_name": "Marybeth Whitney", 
                    "phone": "704-355-1409"
                }, 
                "facility": {
                    "address": {
                        "city": "Charlotte", 
                        "country": "United States", 
                        "state": "North Carolina", 
                        "zip": "28204"
                    }, 
                    "name": "Carolina NeuroSurgery and Spine Associates/Carolinas Rehabilitation"
                }, 
                "investigator": [
                    {
                        "last_name": "Domagoj Coric, MD", 
                        "role": "Principal Investigator"
                    }, 
                    {
                        "last_name": "William Bockenek, MD", 
                        "role": "Principal Investigator"
                    }
                ], 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "1", 
        "official_title": "Pilot Study of Clinical Safety of the PLGA Poly-L-Lysine Scaffold for the Treatment of Complete (ASIA A) Traumatic Acute Spinal Cord Injury", 
        "overall_contact": {
            "email": "kneff@invivotherapeutics.com", 
            "last_name": "Kristin Neff", 
            "phone": "617-863-5581"
        }, 
        "overall_official": {
            "affiliation": "InVivo Therapeutics", 
            "last_name": "Lou Vaickus, MD", 
            "role": "Study Director"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "February 2016", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Incidence of all Adverse Device Effects of any kind/seriousness.", 
            "time_frame": "6 months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02138110"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "measure": "ASIA score changes from baseline at 3 months, 6 months, and 12 months post implantation.", 
            "time_frame": "6 months"
        }, 
        "source": "InVivo Therapeutics", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "InVivo Therapeutics", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "April 2014", 
        "study_design": "Endpoint Classification: Safety Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "May 2014"
    }
}